Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …

With the recent approval of several new antiretrovirals and with new research regarding the
efficacy and safety of HAART comes a necessary revisiting of the timing of initiation of …

Highly active antiretroviral therapy (HAART) refers to a broad category of treatment regimens
usually comprised of three or more antiretroviral drugs that, in previously untreated HIV-1 …

The introduction of highly active antiretroviral therapy (HAART) in 1996 has transformed a
lethal disease to a chronic pathology with a dramatic decrease in mortality and morbidity of …

The development and implementation of highly active antiretroviral therapy (HAART) for the
treatment of the human immunodeficiency virus has revolutionised the care of patients with …

Although the importance of the initial regimen in highly active antiretroviral therapy (HAART)
has been emphasized, the effect on clinical outcome of early modification of the initial …

Objective: To verify the effectiveness of highly active antiretroviral therapy (HAART) and to
identify any factors predictive of clinical outcome in a clinical setting. Design: Observational …

We assessed the risk of acquired immunodeficiency syndrome (AIDS)-related opportunistic
illness or death among persons first prescribed highly active antiretroviral therapy (HAART) …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

When antiretroviral therapy first became available, it was hypothesized that the modest
clinical benefits seen in patients with advanced disease [1] would be more pronounced in …